Join a global symposium exploring Hemophilia and Antiphospholipid Syndrome (APS) with patient stories and expert insights for ...

KAIST scientists have created a fast-acting, stable powder hemostat that stops bleeding in one second and could significantly improve survival in combat and emergency medicine. Severe blood loss ...

A breakthrough study features a biomedical engineering innovation with the potential to transform trauma care and surgical practices. A scientific research team has developed platelet-like particles ...

Prolytix, a U.S.-based bioanalytical leader, has acquired 60 validated thrombosis and hemostasis assays from Hemostasis Reference Laboratory (HRL).

Named among the 250 best inventions of 2024, the Quantra Hemostasis System provides comprehensive blood analysis detailing hemostasis in the operating room in less than 15 minutes DURHAM, ...

Haemonetics Corporation HAE announced receipt of the FDA 510(k) clearance for the TEG 6s hemostasis analyzer system Global Hemostasis-HN assay cartridge. This new cartridge expands Haemonetics' TEG 6s ...

A new study reveals the use of a potassium ferrate hemostatic patch (PFHP) reduces the time to hemostasis for patients receiving cardiac catherization. The findings indicate a faster approach to ...

The glycoprotein V of the blood platelets is an important switch point for hemostasis and thrombus formation. This new finding could have great clinical potential. When our blood vessels are injured ...

A topical hemostatic patch placed under a standard air-bladder bracelet reduces the time to hemostasis after transradial cardiac catheterization without increasing complications, according to results ...

The hemostatic system is maintained by a delicate balance of pro- and anticoagulant factors, allowing for physiologic response to hemorrhage while simultaneously avoiding development of pathologic ...

Haemonetics' plasma and hemostasis franchises show solid growth potential, but macro headwinds and competition cloud the near ...

CEO Christopher Simon reported third-quarter revenue of $349 million, a 4% increase on a reported basis, with adjusted EPS rising 14% to $1.19. He highlighted the company's long-range plan driving ...